Jingwei Shao

Researcher

Last publication 2025 Last refreshed 2026-05-16

faculty

8 h-index 11 pubs 343 cited

Biography and Research Information

OverviewAI-generated summary

Jingwei Shao studies targeted protein degradation utilizing PROTAC (proteolysis-targeting chimera) technology. Their work includes the development of O'PROTAC, a programmable oligonucleotide-based PROTAC system capable of degrading DNA-binding proteins like LEF1 and ERG. Shao has also investigated the role of inositol as a natural inhibitor of mitochondrial fission by targeting AMPK and explored CD36-mediated endocytosis of PROTACs. Further research has focused on the synthesis of PROTAC components, such as VH032 amine, and the identification of new cereblon ligands like 3-aminophthalic acid for O'PROTAC applications. Shao has a publication record of 11 papers with 331 citations and an h-index of 8. Key collaborators at the University of Arkansas for Medical Sciences include Anupreet Kharbanda and Phuc Tran.

Metrics

  • h-index: 8
  • Publications: 11
  • Citations: 343

Selected Publications

  • CD36-mediated endocytosis of proteolysis-targeting chimeras (2025)
    34 citations DOI OpenAlex
  • Feasible Column Chromatography-Free, Multi-Gram Scale Synthetic Process of VH032 Amine, Which Could Enable Rapid PROTAC Library Construction (2022)
    15 citations DOI OpenAlex
  • 3-Aminophthalic acid, a new cereblon ligand for targeted protein degradation by O’PROTAC (2022)
    18 citations DOI OpenAlex
  • Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPK (2021)
    82 citations DOI OpenAlex
  • Destruction of DNA‐Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG (2021)
    115 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

57 Collaborators 20 Institutions 3 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics